The HCPLive HIV/AIDS page is a comprehensive resource for clinical news and insights on human immunodeficiency virus. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for HIV, and more.
September 28th 2023
Results from the systematic review and meta-analysis showed FMT restored the normal microbiome, reduced the risk of gastrointestinal infections, and did not lead to increased adverse events in patients with HIV.
December 15th 2021
September 13th 2021
Serious Liver Disease Rates Higher Among Coinfected Patients
March 21st 2014Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
Investigational Antiviral Offers Benefit in Patients Co-Infected with Hepatitis C, HIV
November 6th 2013A novel direct-acting antiviral (DAA) targeting a protein associated with hepatitis C (HCV) also has antiviral activity against HIV-1 and shows benefit in co-infected individuals when added to pegylated interferon and ribavirin treatment (PR).
Hepatitis C Treatment Following Referral Associated with Marital Status, HIV Presence
October 4th 2013Study finds there are often long delays between diagnosis and referral for treatment by a specialist for patients with hepatitis C, and also long delays from the time of referral to initiation of treatment.
Victories and Challenges in Hepatitis Testing: New USPSTF Guidelines and the Affordable Care Act
September 11th 2013Recently released testing guidelines and expanded access to insurance coverage under the ACA may improve awareness and treatment among HIV-positive, economically underserved, and minority populations that are disproportionately impacted by viral hepatitis infection.
Once-Daily Complera as Effective as Atripla, Though with Fewer Side Effects
Study results presented at the 2013 United States Conference on AIDS show that both combo drugs have a similar efficacy profile in ART-naïve patients, but patients treated with Complera reported fewer and less severe side effects.
Many HIV-Positive Patients Suffer Cognitive Impairments That Can Affect Treatment Outcomes
Researchers found that overall cognitive performance was below average in a sample of patients with HIV who were referred for neurocognitive evaluation. Especially affected were areas involving memory, which can have a negative effect on treatment adherence.
More Effective Treatment of HIV Patients Possible Through Pay for Performance Model
Increased spending for treatment of HIV patients does not necessarily lead to a more positive clinical outcome, according to a new study presented at the 2013 United States Conference on AIDS.
Linkage to Care Programs May Help in Reducing HIV Transmission
September 10th 2013By providing HIV testing, counseling, screening for other STDs, transportation assistance, and other services, these programs were able to successfully identify new cases of HIV in high-risk groups and provide them with follow-up care.